Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

BioEscalator Portfolio 2026

The second edition of our Portfolio, a valuable guide to the BioEscalator tenant community for investors, partners and anyone interested in biomedical innovation, has been published. With an introduction from Charlotte Casebourne Stock, Executive Partner at Yarvie and co-founder of Theolytics, plus profiles of 14 companies creating the future of healthcare, it brings an exciting insight into the R&D taking place here.

BioEscalator Portfolio 2025

The BioEscalator is very proud to be home to a stellar collection of companies using cutting-edge science to tackle profound medical challenges. Our new Portfolio 2025 brings them together to showcase their innovative approaches and provide a valuable guide for potential investors and partners.